We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.97%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$126B
AUM Growth
+$5.23B
(+4.3%)
Cap. Flow
-$4.63B
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
346
New
11
Increased
124
Reduced
177
Closed
13
Avg Time Held
6.9
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$421M |
| 2 |
Amazon
AMZN
|
+$401M |
| 3 |
ConocoPhillips
COP
|
+$282M |
| 4 |
Danaher
DHR
|
+$217M |
| 5 |
Flutter Entertainment
FLUT
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.04B |
| 2 |
Sony
SONY
|
+$581M |
| 3 |
Micron Technology
MU
|
+$543M |
| 4 |
Amgen
AMGN
|
+$498M |
| 5 |
Adobe
ADBE
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.56% |
| 2 | Healthcare | 25.76% |
| 3 | Industrials | 11.23% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
United Airlines
UAL
$32.9B
| $1.5B | 1.19% |
18,834,710
-2,964,935
| -14% | -$218M |
2013 Q2
48 quarters
|
|
27
JPMorgan Chase
JPM
$891B
| $1.46B | 1.16% |
5,045,127
-3,253
| -0.1% | -$830K |
2015 Q1
41 quarters
|
|
28
Wells Fargo
WFC
$248B
| $1.46B | 1.15% |
18,177,960
-3,724,689
| -17% | -$269M |
2013 Q2
48 quarters
|
|
29
TJX Companies
TJX
$159B
| $1.42B | 1.13% |
11,536,892
-164,175
| -1% | -$20.8M |
2013 Q2
48 quarters
|
|
30
Ross Stores
ROST
$75B
| $1.31B | 1.04% |
10,268,700
+51,765
| +0.5% | +$7.18M |
2013 Q2
48 quarters
|
|
31
Novartis
NVS
$286B
| $1.26B | 1% |
10,401,434
+18,555
| +0.2% | +$2.09M |
2013 Q2
48 quarters
|
|
32
BeOne Medicines Ltd
ONC
$42.3B
| $1.23B | 0.98% |
5,088,279
+32,775
| +0.6% | +$8.04M |
2017 Q2
32 quarters
|
|
33
NetApp
NTAP
$42.2B
| $1.19B | 0.94% |
11,166,845
-335,245
| -3% | -$31.8M |
2013 Q2
48 quarters
|
|
34
Aecom
ACM
$7.6B
| $1.08B | 0.86% |
9,563,252
-585,478
| -6% | -$60.8M |
2013 Q2
48 quarters
|
|
35
GSK
GSK
$98.2B
| $1.06B | 0.84% |
27,726,780
+2,018,760
| +8% | +$77.1M |
2013 Q2
48 quarters
|
|
36
Bristol-Myers Squibb
BMY
$124B
| $1.06B | 0.84% |
22,944,650
-25,983
| -0.1% | -$1.28M |
2017 Q1
33 quarters
|
|
37
DELISTED
Hess
HES
| $1.06B | 0.84% |
7,652,265
+521,890
| +7% | +$70.5M |
2018 Q3
27 quarters
|
|
38
Baidu
BIDU
$28.1B
| $1.04B | 0.82% |
12,116,750
+170,414
| +1% | +$14.7M |
2019 Q4
22 quarters
|
|
39
Intuit
INTU
$88.2B
| $1.03B | 0.82% |
1,307,737
-76,828
| -6% | -$52M |
2013 Q2
48 quarters
|
|
40
Royal Caribbean
RCL
$74.9B
| $994M | 0.79% |
3,175,668
-373,100
| -11% | -$88.8M |
2013 Q2
48 quarters
|
|
41
Delta Air Lines
DAL
$51.4B
| $993M | 0.79% |
20,193,832
-1,213,815
| -6% | -$55.7M |
2013 Q2
48 quarters
|
|
42
Northern Trust
NTRS
$30.3B
| $988M | 0.78% |
7,793,757
+1,270,748
| +19% | +$130M |
2016 Q1
37 quarters
|
|
43
Thermo Fisher Scientific
TMO
$258B
| $976M | 0.77% |
2,406,192
+88,890
| +4% | +$37.2M |
2013 Q4
46 quarters
|
|
44
BioMarin Pharmaceuticals
BMRN
$10.8B
| $867M | 0.69% |
15,772,173
-2,001,108
| -11% | -$118M |
2013 Q2
48 quarters
|
|
45
TransDigm Group
TDG
$62.7B
| $848M | 0.67% |
557,923
+45,079
| +9% | +$63.3M |
2013 Q4
46 quarters
|
|
46
Analog Devices
ADI
$196B
| $820M | 0.65% |
3,446,280
-31,365
| -0.9% | -$6.53M |
2013 Q2
48 quarters
|
|
47
Walt Disney
DIS
$191B
| $787M | 0.62% |
6,345,497
+151,073
| +2% | +$15.7M |
2013 Q2
48 quarters
|
|
48
Meta Platforms (Facebook)
META
$1.88T
| $751M | 0.6% |
1,017,530
+108,620
| +12% | +$67.1M |
2018 Q1
29 quarters
|
|
49
Jabil
JBL
$30.1B
| $744M | 0.59% |
3,410,410
+24,650
| +0.7% | +$4M |
2013 Q2
48 quarters
|
|
50
Elanco Animal Health
ELAN
$11.8B
| $739M | 0.59% |
51,766,814
+1,543,279
| +3% | +$18M |
2018 Q3
27 quarters
|
|
Similar funds
Primecap Management's Q2 2025 Portfolio in Review
As of Q2 2025, Primecap Management held 346 positions worth $126B, up 4.3% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $4.63B in Q2 2025, closing 13 positions and reducing 177 holdings. Its most notable exit was Discover Financial Services, an estimated $98.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Capital One worth $116M.
- Primecap Management's largest Q2 2025 buy was Capital One: 545,321 shares worth $116M.
- Primecap Management added most to Charles Schwab in Q2 2025, an estimated $421M increase.
- Primecap Management's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $2.04B.
- Primecap Management fully exited Discover Financial Services in Q2 2025, selling an estimated $98.1M.
- Primecap Management's ten largest holdings make up 32% of its $126B portfolio in Q2 2025.
- Primecap Management opened 11 new positions and closed 13 in Q2 2025.
- Primecap Management's portfolio value rose 4.3% quarter-over-quarter to $126B.
Based on Primecap Management's 13F filing for Q2 2025, filed 11 Aug 2025.